MedTrace Logo

PRP in 2ry Spontaneous Pneumothorax

NCT03830645 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-06-30

No results posted yet for this study

Summary

secondary spontaneous pneumothorax patients will be enrolled ,all of them will receive PRP with different doses and schedules

Conditions

  • Pneumothorax Spontaneous Secondary

Interventions

BIOLOGICAL

Platelet Rich Plasma

Application of platelet rich plasma through the intercostal tube into the pleural space

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-05
Primary Completion
2020-11-30
Completion
2020-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03830645 on ClinicalTrials.gov